Maeda T, Takase M, Ishibashi A, Yamamoto T, Sasaki K, Arika T, Yokoo M, Amemiya K
Central Research Laboratories, Kaken Pharmaceutical Co., Ltd., Tokyo, Japan.
Yakugaku Zasshi. 1991 Feb;111(2):126-37. doi: 10.1248/yakushi1947.111.2_126.
In screening of new antifungal agents, bis(naphthalenemethyl)amines were found to have more potent antifungal activity than clotrimazole. Studies on their structure-activity relationships indicated that benzylamines had potent antifungal activity. Among them, butenafine hydrochloride (N-p-tert-butylbenzyl-N-methyl-1-naphthalenemethylamine hydrochloride, KP-363) has proved to show the strongest activity. It exhibits a wide spectrum activity in vitro against particularly dermatophytes (87 strains; minimal inhibitory concentration (MIC) range, 0.0015 to 0.05 microgram/ml), and also against Aspergillus (15 strains; MIC range, 0.025 to 0.78 microgram/ml), Cryptococcus neoformans (4 strains; MICs 0.78 and 1.56 micrograms/ml) and yeasts of genus Candida (67 strains; MIC range, 3.13 to greater than 100 micrograms/ml).
在新型抗真菌药物的筛选过程中,发现双(萘甲基)胺类化合物的抗真菌活性比克霉唑更强。对其构效关系的研究表明,苄胺类化合物具有较强的抗真菌活性。其中,盐酸布替萘芬(N-对叔丁基苄基-N-甲基-1-萘甲基胺盐酸盐,KP-363)已被证明具有最强的活性。它在体外表现出广泛的活性,尤其对皮肤癣菌(87株;最低抑菌浓度(MIC)范围为0.0015至0.05微克/毫升)、曲霉属(15株;MIC范围为0.025至0.78微克/毫升)、新型隐球菌(4株;MIC为0.78和1.56微克/毫升)以及念珠菌属酵母菌(67株;MIC范围为3.13至大于100微克/毫升)均有活性。